Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.10
PDCO's Cash-to-Debt is ranked lower than
90% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.74 vs. PDCO: 0.10 )
Ranked among companies with meaningful Cash-to-Debt only.
PDCO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 0.7 Max: No Debt
Current: 0.1
Equity-to-Asset 0.39
PDCO's Equity-to-Asset is ranked lower than
57% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. PDCO: 0.39 )
Ranked among companies with meaningful Equity-to-Asset only.
PDCO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.36  Med: 0.61 Max: 0.78
Current: 0.39
0.36
0.78
Interest Coverage 7.13
PDCO's Interest Coverage is ranked lower than
66% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.18 vs. PDCO: 7.13 )
Ranked among companies with meaningful Interest Coverage only.
PDCO' s Interest Coverage Range Over the Past 10 Years
Min: 6.95  Med: 11.64 Max: 28.08
Current: 7.13
6.95
28.08
Piotroski F-Score: 6
Altman Z-Score: 3.88
Beneish M-Score: -2.44
WACC vs ROIC
8.33%
8.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 5.32
PDCO's Operating Margin % is ranked higher than
61% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.02 vs. PDCO: 5.32 )
Ranked among companies with meaningful Operating Margin % only.
PDCO' s Operating Margin % Range Over the Past 10 Years
Min: 5.32  Med: 10.55 Max: 12
Current: 5.32
5.32
12
Net Margin % 3.12
PDCO's Net Margin % is ranked higher than
51% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.12 vs. PDCO: 3.12 )
Ranked among companies with meaningful Net Margin % only.
PDCO' s Net Margin % Range Over the Past 10 Years
Min: 3.12  Med: 6.24 Max: 7.5
Current: 3.12
3.12
7.5
ROE % 12.46
PDCO's ROE % is ranked higher than
63% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.89 vs. PDCO: 12.46 )
Ranked among companies with meaningful ROE % only.
PDCO' s ROE % Range Over the Past 10 Years
Min: 12.46  Med: 15.1 Max: 18.86
Current: 12.46
12.46
18.86
ROA % 4.92
PDCO's ROA % is ranked higher than
69% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.95 vs. PDCO: 4.92 )
Ranked among companies with meaningful ROA % only.
PDCO' s ROA % Range Over the Past 10 Years
Min: 4.92  Med: 8.53 Max: 11.2
Current: 4.92
4.92
11.2
ROC (Joel Greenblatt) % 25.28
PDCO's ROC (Joel Greenblatt) % is ranked higher than
65% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.27 vs. PDCO: 25.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PDCO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 25.28  Med: 58.52 Max: 78.86
Current: 25.28
25.28
78.86
3-Year Revenue Growth Rate 16.20
PDCO's 3-Year Revenue Growth Rate is ranked higher than
80% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.40 vs. PDCO: 16.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PDCO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.9  Med: 12.4 Max: 18.9
Current: 16.2
6.9
18.9
3-Year EBITDA Growth Rate 4.50
PDCO's 3-Year EBITDA Growth Rate is ranked lower than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.50 vs. PDCO: 4.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PDCO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -2  Med: 8.1 Max: 25.9
Current: 4.5
-2
25.9
3-Year EPS without NRI Growth Rate -2.20
PDCO's 3-Year EPS without NRI Growth Rate is ranked lower than
79% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.00 vs. PDCO: -2.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
PDCO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -3.7  Med: 8.6 Max: 24.1
Current: -2.2
-3.7
24.1
GuruFocus has detected 2 Warning Signs with Patterson Companies Inc $PDCO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PDCO's 10-Y Financials

Financials (Next Earnings Date: 2017-05-24 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

PDCO Guru Trades in Q1 2016

Robert Olstein 254,700 sh (+10.74%)
Third Avenue Management 109,335 sh (unchged)
Tom Gayner 168,000 sh (unchged)
Jeremy Grantham Sold Out
Mairs and Power 1,380,227 sh (-0.44%)
Mario Gabelli 1,605,561 sh (-5.36%)
Paul Tudor Jones 9,300 sh (-23.14%)
» More
Q2 2016

PDCO Guru Trades in Q2 2016

Jerome Dodson 440,000 sh (New)
Joel Greenblatt 273,181 sh (New)
Jim Simons 194,304 sh (New)
Ray Dalio 6,400 sh (New)
Mairs and Power 1,534,775 sh (+11.20%)
Third Avenue Management 109,335 sh (unchged)
Tom Gayner 168,000 sh (unchged)
Robert Olstein 245,335 sh (-3.68%)
Mario Gabelli 1,487,961 sh (-7.32%)
Paul Tudor Jones 7,900 sh (-15.05%)
» More
Q3 2016

PDCO Guru Trades in Q3 2016

Mairs and Power 1,923,561 sh (+25.33%)
Robert Olstein 273,915 sh (+11.65%)
Jerome Dodson 440,000 sh (unchged)
Tom Gayner 168,000 sh (unchged)
Ray Dalio Sold Out
Jim Simons 193,604 sh (-0.36%)
Mario Gabelli 1,461,111 sh (-1.80%)
Paul Tudor Jones 6,600 sh (-16.46%)
Third Avenue Management 75,716 sh (-30.75%)
Joel Greenblatt 126,875 sh (-53.56%)
» More
Q4 2016

PDCO Guru Trades in Q4 2016

Steven Cohen 369,500 sh (New)
First Pacific Advisors 45,000 sh (New)
Richard Pzena 5,082 sh (New)
Robert Olstein 352,605 sh (+28.73%)
Jerome Dodson 531,000 sh (+20.68%)
Mairs and Power 2,308,802 sh (+20.03%)
Tom Gayner 168,000 sh (unchged)
Joel Greenblatt Sold Out
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Third Avenue Management 75,400 sh (-0.42%)
Mario Gabelli 1,423,116 sh (-2.60%)
» More
» Details

Insider Trades

Latest Guru Trades with PDCO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 423450    SIC: 5047
Compare: » details
Traded in other countries:PD2.Germany,
Patterson Companies Inc is a distributors of dental products in North America. The Company operates in three business segments: dental supply, veterinary supply and rehabilitation supply.

Based in Minnesota, Patterson is a premier distributor within the dentistry, veterinarian, and production animal markets. Those segments represent roughly 42%, 30%, and 27% of total revenue, respectively. Patterson also sells practice operating software and additional services, including consulting, equipment financing, and repair services. Approximately 20% of Patterson's sales are outside the United States.

Top Ranked Articles about Patterson Companies Inc

Jerome Dodson Goes 3 for 3 in Second Quarter Dodson gains 3 new holdings, sells 3
Investor Jerome Dodson (Trades, Portfolio) of the Parnassus Fund gained three new holdings and sold out three holdings during the second quarter. Read more...
Jerome Dodson Purchases Shares of Patterson Companies Patterson Companies has reported solid revenue per share growth over the previous 10 years
During the second quarter, Jerome Dodson (Trades, Portfolio) purchased a 440,000-share stake in Patterson Companies Inc. The trade had a 3.08% impact on Dodson’s portfolio. Read more...

Ratios

vs
industry
vs
history
PE Ratio 24.56
PDCO's PE Ratio is ranked lower than
62% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.50 vs. PDCO: 24.56 )
Ranked among companies with meaningful PE Ratio only.
PDCO' s PE Ratio Range Over the Past 10 Years
Min: 9.51  Med: 19.65 Max: 26.17
Current: 24.56
9.51
26.17
Forward PE Ratio 18.21
PDCO's Forward PE Ratio is ranked lower than
71% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.08 vs. PDCO: 18.21 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 24.16
PDCO's PE Ratio without NRI is ranked lower than
62% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.15 vs. PDCO: 24.16 )
Ranked among companies with meaningful PE Ratio without NRI only.
PDCO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.51  Med: 19.9 Max: 33.24
Current: 24.16
9.51
33.24
Price-to-Owner-Earnings 29.33
PDCO's Price-to-Owner-Earnings is ranked lower than
72% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.43 vs. PDCO: 29.33 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
PDCO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.42  Med: 23.3 Max: 95.28
Current: 29.33
12.42
95.28
PB Ratio 3.13
PDCO's PB Ratio is ranked lower than
63% of the 57 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.55 vs. PDCO: 3.13 )
Ranked among companies with meaningful PB Ratio only.
PDCO' s PB Ratio Range Over the Past 10 Years
Min: 1.8  Med: 2.93 Max: 4.53
Current: 3.13
1.8
4.53
PS Ratio 0.77
PDCO's PS Ratio is ranked higher than
58% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.19 vs. PDCO: 0.77 )
Ranked among companies with meaningful PS Ratio only.
PDCO' s PS Ratio Range Over the Past 10 Years
Min: 0.65  Med: 1.1 Max: 1.96
Current: 0.77
0.65
1.96
Price-to-Free-Cash-Flow 25.88
PDCO's Price-to-Free-Cash-Flow is ranked lower than
83% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.81 vs. PDCO: 25.88 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PDCO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.27  Med: 20.66 Max: 333.08
Current: 25.88
9.27
333.08
Price-to-Operating-Cash-Flow 19.00
PDCO's Price-to-Operating-Cash-Flow is ranked lower than
71% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.16 vs. PDCO: 19.00 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PDCO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.34  Med: 17.48 Max: 275.91
Current: 19
8.34
275.91
EV-to-EBIT 17.84
PDCO's EV-to-EBIT is ranked lower than
53% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.10 vs. PDCO: 17.84 )
Ranked among companies with meaningful EV-to-EBIT only.
PDCO' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.6  Med: 12.5 Max: 21.5
Current: 17.84
6.6
21.5
EV-to-EBITDA 13.89
PDCO's EV-to-EBITDA is ranked lower than
60% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.81 vs. PDCO: 13.89 )
Ranked among companies with meaningful EV-to-EBITDA only.
PDCO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.1  Med: 11.2 Max: 18.4
Current: 13.89
6.1
18.4
PEG Ratio 9.68
PDCO's PEG Ratio is ranked lower than
93% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.97 vs. PDCO: 9.68 )
Ranked among companies with meaningful PEG Ratio only.
PDCO' s PEG Ratio Range Over the Past 10 Years
Min: 0.94  Med: 2.22 Max: 28.11
Current: 9.68
0.94
28.11
Shiller PE Ratio 22.12
PDCO's Shiller PE Ratio is ranked higher than
72% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.23 vs. PDCO: 22.12 )
Ranked among companies with meaningful Shiller PE Ratio only.
PDCO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 13.79  Med: 21.66 Max: 39.26
Current: 22.12
13.79
39.26
Current Ratio 1.89
PDCO's Current Ratio is ranked higher than
61% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. PDCO: 1.89 )
Ranked among companies with meaningful Current Ratio only.
PDCO' s Current Ratio Range Over the Past 10 Years
Min: 0.95  Med: 2.72 Max: 3.71
Current: 1.89
0.95
3.71
Quick Ratio 1.06
PDCO's Quick Ratio is ranked higher than
51% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.06 vs. PDCO: 1.06 )
Ranked among companies with meaningful Quick Ratio only.
PDCO' s Quick Ratio Range Over the Past 10 Years
Min: 0.73  Med: 1.96 Max: 2.79
Current: 1.06
0.73
2.79
Days Inventory 67.63
PDCO's Days Inventory is ranked lower than
66% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 42.23 vs. PDCO: 67.63 )
Ranked among companies with meaningful Days Inventory only.
PDCO' s Days Inventory Range Over the Past 10 Years
Min: 47.47  Med: 50.33 Max: 67.63
Current: 67.63
47.47
67.63
Days Sales Outstanding 52.79
PDCO's Days Sales Outstanding is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.92 vs. PDCO: 52.79 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDCO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.31  Med: 50.38 Max: 61.86
Current: 52.79
44.31
61.86
Days Payable 46.79
PDCO's Days Payable is ranked lower than
64% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 74.61 vs. PDCO: 46.79 )
Ranked among companies with meaningful Days Payable only.
PDCO' s Days Payable Range Over the Past 10 Years
Min: 31.98  Med: 36.27 Max: 50.86
Current: 46.79
31.98
50.86

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.17
PDCO's Dividend Yield % is ranked higher than
71% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. PDCO: 2.17 )
Ranked among companies with meaningful Dividend Yield % only.
PDCO' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.57 Max: 2.41
Current: 2.17
0.31
2.41
Dividend Payout Ratio 0.52
PDCO's Dividend Payout Ratio is ranked lower than
71% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.32 vs. PDCO: 0.52 )
Ranked among companies with meaningful Dividend Payout Ratio only.
PDCO' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.29 Max: 0.52
Current: 0.52
0.06
0.52
3-Year Dividend Growth Rate 15.80
PDCO's 3-Year Dividend Growth Rate is ranked higher than
68% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.90 vs. PDCO: 15.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
PDCO' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 79.7
Current: 15.8
0
79.7
Forward Dividend Yield % 2.34
PDCO's Forward Dividend Yield % is ranked higher than
69% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.85 vs. PDCO: 2.34 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.74
PDCO's 5-Year Yield-on-Cost % is ranked higher than
64% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.01 vs. PDCO: 4.74 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
PDCO' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.68  Med: 3.43 Max: 5.26
Current: 4.74
0.68
5.26
3-Year Average Share Buyback Ratio 2.10
PDCO's 3-Year Average Share Buyback Ratio is ranked higher than
97% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: -3.00 vs. PDCO: 2.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PDCO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.1  Med: 0.3 Max: 5.1
Current: 2.1
-1.1
5.1

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 31.32
PDCO's Price-to-Tangible-Book is ranked lower than
96% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.84 vs. PDCO: 31.32 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PDCO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.45  Med: 9.87 Max: 571.08
Current: 31.32
4.45
571.08
Price-to-Intrinsic-Value-Projected-FCF 1.29
PDCO's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
62% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.87 vs. PDCO: 1.29 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PDCO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.69  Med: 1.45 Max: 3.33
Current: 1.29
0.69
3.33
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.26
PDCO's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
100% of the 9 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.40 vs. PDCO: 2.26 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.70
PDCO's Price-to-Median-PS-Value is ranked higher than
88% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. PDCO: 0.70 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PDCO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.65  Med: 1.25 Max: 2.63
Current: 0.7
0.65
2.63
Price-to-Graham-Number 5.80
PDCO's Price-to-Graham-Number is ranked lower than
95% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.78 vs. PDCO: 5.80 )
Ranked among companies with meaningful Price-to-Graham-Number only.
PDCO' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 2.14  Med: 3.05 Max: 27.09
Current: 5.8
2.14
27.09
Earnings Yield (Greenblatt) % 5.61
PDCO's Earnings Yield (Greenblatt) % is ranked higher than
53% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.35 vs. PDCO: 5.61 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PDCO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 4.7  Med: 8 Max: 15.1
Current: 5.61
4.7
15.1
Forward Rate of Return (Yacktman) % 6.43
PDCO's Forward Rate of Return (Yacktman) % is ranked lower than
66% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.57 vs. PDCO: 6.43 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PDCO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 3.1  Med: 11.6 Max: 25.9
Current: 6.43
3.1
25.9

More Statistics

Revenue (TTM) (Mil) $5,602
EPS (TTM) $ 1.82
Beta0.92
Short Percentage of Float12.46%
52-Week Range $36.46 - 50.40
Shares Outstanding (Mil)97.13

Analyst Estimate

Apr17 Apr18 Apr19 Apr20
Revenue (Mil $) 5,687 5,865 6,040 6,401
EPS ($) 2.39 2.56 2.74 3.10
EPS without NRI ($) 2.39 2.56 2.74 3.10
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.22%
Dividends per Share ($) 0.96 1.03 1.17
» More Articles for PDCO

Headlines

Articles On GuruFocus.com
Gurus' Worst Recent Investments Feb 15 2017 
Economic Forces, More than Politics, Drive Stocks Nov 30 2016 
Jerome Dodson Goes 3 for 3 in Second Quarter Jul 21 2016 
Jerome Dodson Purchases Shares of Patterson Companies Inc Jul 20 2016 
Estimate for Patterson Companies' Intrinsic Value Equals the Market Price Mar 24 2015 
Mario Gabelli on Aging America, Alcohol, Twitter, Facebook Dec 17 2013 
Mario Gabelli’s Best Value Plays Nov 21 2012 
Owens & Minor Inc. (OMI) Dividend Stock Analysis Aug 03 2012 
The Best Dividends on April 9, 2012 Apr 06 2012 
Owens & Minor Inc. (OMI) Dividend Stock Analysis Sep 16 2011 

More From Other Websites
Coverage initiated on Patterson Companies by Deutsche Bank Mar 15 2017
Patterson (PDCO) Rewards Shareholders with 8% Dividend Hike Mar 15 2017
Patterson Companies Increases Cash Dividend by 8 Percent Mar 14 2017
PATTERSON COMPANIES, INC. Financials Mar 11 2017
PATTERSON COMPANIES, INC. Files SEC form 10-Q, Quarterly Report Mar 08 2017
Patterson Cos. Could Hike Dividend Soon Mar 07 2017
Patterson Cos., Inc. : PDCO-US: Dividend Analysis : January 13th, 2017 (record date) : By the... Mar 06 2017
Jerome Dodson Adds to 9 Positions in 4th Quarter Mar 01 2017
Patterson Cos., Inc. :PDCO-US: Earnings Analysis: Q3, 2017 By the Numbers : February 28, 2017 Feb 28 2017
PATTERSON COMPANIES, INC. Files SEC form 8-K, Other Events Feb 28 2017
Edited Transcript of PDCO earnings conference call or presentation 23-Feb-17 3:00pm GMT Feb 23 2017
Patterson Companies (PDCO) Earnings Beat Estimates in Q3 Feb 23 2017
PATTERSON COMPANIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 23 2017
Patterson Companies (PDCO) Q3 Earnings Beat, Sales Miss Feb 23 2017
Patterson Cos. tops 3Q profit forecasts Feb 23 2017
Patterson Cos. tops 3Q profit forecasts Feb 23 2017
Q3 2017 Patterson Companies Inc Earnings Release - Before Market Open Feb 23 2017
Patterson Companies Reports Fiscal 2017 Third-Quarter Operating Results Feb 23 2017
MedTech Stocks' Earnings Due on Feb 23: TFX, SAUHF, BIO, PDCO Feb 22 2017
Patterson Companies (PDCO) Q3 Earnings: What's in Store? Feb 21 2017
Gurus' Worst Recent Investments Feb 15 2017
Patterson Companies Third-Quarter Fiscal 2017 Conference Call Scheduled for Thursday, February 23,... Feb 09 2017
Dave Misiak Named President of Patterson Dental North America and Dave Lardy Named Chief Information... Oct 28 2016
Heartland Dental, the largest dental support organization in the U.S., selects Patterson Dental as... Oct 21 2016
Patterson Dental offers disaster relief to East coast customers affected by Hurricane Matthew Oct 11 2016
Patterson Dental announces sponsorship of ADA Success program Sep 08 2016
Patterson Dental offers disaster relief to Louisiana customers Aug 18 2016
Patterson Dental offers disaster relief to West Virginia customers Jul 07 2016
Patterson Fulfillment Center employees complete annual product quality control training and testing May 16 2016
Patterson Companies is a proud sponsor of the American Red Cross Minnesota Region's Heroes... May 06 2016
Patterson Dental offers assistance to flood-impacted Houston dentists Apr 26 2016
Patterson Companies named to Forbes 2016 list of America's best employers. Apr 22 2016
Patterson Companies placed on Honor Roll for 2015 Minnesota Census of Women in Corporate Leadership. Apr 22 2016
Patterson to buy private veterinary products maker for $1.1 billion May 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)